Characteristics of included patients and PODCI scores according to group
| . | Patients with CVC-related thrombosis (n = 223) . | Patients with non–CVC-related thrombosis (n = 33) . | P . |
|---|---|---|---|
| Age at time of first DVT, mo | 3.5 (0.7-18.7) | 177.6 (149.6-194.8) | <.001 |
| Female sex | 102 (46) | 23 (70) | .02 |
| Underlying condition | — | ||
| CHD | 107 (48) | 0 (0) | |
| Infection | 24 (11) | 3 (9) | |
| Prematurity | 20 (9) | 0 (0) | |
| Congenital diaphragmatic hernia | 16 (7) | 0 (0) | |
| Cancer | 15 (7) | 5 (15) | |
| Organ transplantation | 13 (6) | 1 (3) | |
| Postsurgery | 10 (4) | 0 (0) | |
| Intestinal failure | 4 (2) | 0 (0) | |
| None | 0 (0) | 17 (52) | |
| Inflammation (IBD/lupus) | 0 (0) | 6 (18) | |
| Other | 14 (6) | 1 (3) | |
| Thrombophilia* | <.001 | ||
| None | 122 (78) | 12 (36) | |
| Minor | 28 (18) | 7 (21) | |
| Major | 6 (4) | 14 (43) | |
| PODCI Global Functioning score† | 94 (87-98) | 97 (92-99) | .4 |
| PODCI Happiness score‡ | 95 (81-100) | 91 (75-100) | .6 |
| . | Patients with CVC-related thrombosis (n = 223) . | Patients with non–CVC-related thrombosis (n = 33) . | P . |
|---|---|---|---|
| Age at time of first DVT, mo | 3.5 (0.7-18.7) | 177.6 (149.6-194.8) | <.001 |
| Female sex | 102 (46) | 23 (70) | .02 |
| Underlying condition | — | ||
| CHD | 107 (48) | 0 (0) | |
| Infection | 24 (11) | 3 (9) | |
| Prematurity | 20 (9) | 0 (0) | |
| Congenital diaphragmatic hernia | 16 (7) | 0 (0) | |
| Cancer | 15 (7) | 5 (15) | |
| Organ transplantation | 13 (6) | 1 (3) | |
| Postsurgery | 10 (4) | 0 (0) | |
| Intestinal failure | 4 (2) | 0 (0) | |
| None | 0 (0) | 17 (52) | |
| Inflammation (IBD/lupus) | 0 (0) | 6 (18) | |
| Other | 14 (6) | 1 (3) | |
| Thrombophilia* | <.001 | ||
| None | 122 (78) | 12 (36) | |
| Minor | 28 (18) | 7 (21) | |
| Major | 6 (4) | 14 (43) | |
| PODCI Global Functioning score† | 94 (87-98) | 97 (92-99) | .4 |
| PODCI Happiness score‡ | 95 (81-100) | 91 (75-100) | .6 |
Data are presented as median (25th-75th percentile) or n (%).
CHD, congenital heart disease; IBD, inflammatory bowel disease.
156 (70%) of 223 patients tested in CVC stratum, and 33 (100%) of 33 tested in non-CVC stratum.
Scores available in 97 patients in CVC stratum and 17 patients in non-CVC stratum.
Scores available in 90 patients in CVC stratum and 18 patients in non-CVC stratum.